Search

Author/Creator Doerr, Thomas

1. A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial. Issue 1 (December 2015)

Authors:
Ichinohe, Tatsuo; Kuroda, Yoshiaki; Okamoto, Shinichiro; Matsue, Kosei; Iida, Shinsuke; Sunami, Kazutaka; Komeno, Takuya; Suzuki, Kenshi; Ando, Kiyoshi; Taniwaki, Masafumi; Tobinai, Kensei; Chou, Takaaki; Kaneko, Hitomi; Iwasaki, Hiromi; Uemura, Chie; Tamakoshi, Hiromi; Zaki, Mohamed; Doerr, Thom...
Journal:
Experimental hematology & oncology
Issue:
Volume 5:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial. Issue 1 (December 2015)

Authors:
Ichinohe, Tatsuo; Kuroda, Yoshiaki; Okamoto, Shinichiro; Matsue, Kosei; Iida, Shinsuke; Sunami, Kazutaka; Komeno, Takuya; Suzuki, Kenshi; Ando, Kiyoshi; Taniwaki, Masafumi; Tobinai, Kensei; Chou, Takaaki; Kaneko, Hitomi; Iwasaki, Hiromi; Uemura, Chie; Tamakoshi, Hiromi; Zaki, Mohamed; Doerr, Thom...
Journal:
Experimental hematology & oncology
Issue:
Volume 5:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma. Issue 11 (4th November 2015)

Authors:
Matsue, Kosei; Iwasaki, Hiromi; Chou, Takaaki; Tobinai, Kensei; Sunami, Kazutaka; Ogawa, Yoshiaki; Kurihara, Mari; Midorikawa, Shuichi; Zaki, Mohamed; Doerr, Thomas; Iida, Shinsuke
Journal:
Cancer science
Issue:
Volume 106:Issue 11(2015:Nov.)
Page Start:
1561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial. Issue 6 (June 2019)

Authors:
Richardson, Paul G; Oriol, Albert; Beksac, Meral; Liberati, Anna Marina; Galli, Monica; Schjesvold, Fredrik; Lindsay, Jindriska; Weisel, Katja; White, Darrell; Facon, Thierry; San Miguel, Jesus; Sunami, Kazutaka; O'Gorman, Peter; Sonneveld, Pieter; Robak, Pawel; Semochkin, Sergey; Schey, Steve; Y...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 6(2019)
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗